Bristol Myers Squibb (BMY) stock plunged early Thursday after the drugmaker reported adjusted earnings of $1.67 per share on $12.34 billion in fourth-quarter sales.
↑ X NOW PLAYING How To Buy Stocks: Flat Base Chart PatternOn average, analysts polled by FactSet expected Bristol Myers to earn $1.46 per share and report $11.57 billion in sales.
In the year-earlier period, the pharma company had $1.70 earnings per share and $11.48 billion in sales.
For the year, Bristol Myers guided to earnings of $6.55 to $6.85 per share and $45.5 billion in sales. The Street projected profit of $6.91 per share and $46.29 billion in sales.
In premarket trades on the stock market today, Bristol Myers Squibb stock tumbled more than 4% to 57.25. Shares broke out of a flat base after topping a buy point at 61.08 on Jan. 27, according to MarketSurge. But the stock has since fallen back below that entry.
More to follow.
YOU MAY ALSO LIKE:
Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected.
Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs
Find The Best Long-Term Investments With IBD Long-Term Leaders
Options Trading: How To Start Using Options, How To Manage Risk
Short-Term Trades Can Add Up To Big Profits. IBD's SwingTrader Shows You How
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.